| Oct 2, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $41.03 | $83K |
| Sep 3, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $48.01 | $98K |
| Sep 1, 2026 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | SELL | 4.000K | $35.79 | $300K |
| Aug 17, 2026 | Christian Todd Nichols | SVP, CHIEF COMMERCIAL OFFICER | SELL | 7.576K | $49.23 | $373K |
| Aug 3, 2026 | Nancy Snyderman | DIRECTOR | SELL-OPTIONS | — | $48.53 | $161K |
| Aug 3, 2026 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | SELL | 4.000K | $36.53 | $315K |
| Aug 3, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $48.58 | $99K |
| Jul 6, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $54.03 | $110K |
| Jul 1, 2026 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | SELL | 4.000K | $35.43 | $367K |
| Jun 12, 2026 | Christopher I Wright | DIRECTOR | SELL | 2.000K | $45.10 | $90K |
| Jun 4, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $43.05 | $88K |
| Jun 1, 2026 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | SELL | 4.000K | $30.51 | $278K |
| May 29, 2026 | Samuel Joseph Parisi | VP, FINANCE (INTERIM PAO) | SELL-OPTIONS | — | $30.92 | $371K |
| May 4, 2026 | David Joseph Gaffin | EVP, CLO, ALKERMES, INC. | SELL | 2.034K | $33.20 | $68K |
| May 1, 2026 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | SELL | 4.000K | $26.37 | $204K |
